Physician Resources: High Risk Kidney Donor: New Paradigms in Transplantation
- Recognize which HIV+ ESRD patients are eligible for HIV+ cadaveric transplant through the HOPE U01 Trial and increase patient outcomes
- Identify ESRD, HCV- listed kidney transplant patients that would benefit from receipt of HCV+ cadaveric organ through a IRB approved trial
- Explain which high risk cadaveric kidney offers can be screened through UNET prior to organ offer
Dr. Amit D. Tevar has financial interests with the following entity or entities producing health care goods or services as indicated below:
Other: Dr. Tevar is on the Advisory Board for CSL Behring
All presenters disclosure of relevant financial relationships with any entity producing, marketing, re-selling, or distributing health care goods or services, used on, or consumed by, patients is listed above. No other planners, members of the planning committee, speakers, presenters, authors, content reviewers and/or anyone else in a position to control the content of this education activity have relevant financial relationships to disclose.
The University of Pittsburgh School of Medicine is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.
The University of Pittsburgh School of Medicine designates this enduring material for a maximum of .75 AMA PRA Category 1 Credits ™. Each physician should only claim credit commensurate with the extent of their participation in the activity. Other health care professionals are awarded (0.075) continuing education units (CEU) which are equivalent to .75 contact hour.
- 0.75 AMA PRA Category 1 Credit™The University of Pittsburgh School of Medicine is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.
- 0.75 Attendance